| Product Code: ETC13223973 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Value-based Healthcare Service Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Value-based Healthcare Service Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Value-based Healthcare Service Market Revenues & Volume, 2021 & 2031F |
3.3 North America Value-based Healthcare Service Market - Industry Life Cycle |
3.4 North America Value-based Healthcare Service Market - Porter's Five Forces |
3.5 North America Value-based Healthcare Service Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Value-based Healthcare Service Market Revenues & Volume Share, By Models Type, 2021 & 2031F |
3.7 North America Value-based Healthcare Service Market Revenues & Volume Share, By Payer Type, 2021 & 2031F |
3.8 North America Value-based Healthcare Service Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Value-based Healthcare Service Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Value-based Healthcare Service Market Trends |
6 North America Value-based Healthcare Service Market, 2021 - 2031 |
6.1 North America Value-based Healthcare Service Market, Revenues & Volume, By Models Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Value-based Healthcare Service Market, Revenues & Volume, By Pay for Performance, 2021 - 2031 |
6.1.3 North America Value-based Healthcare Service Market, Revenues & Volume, By Patient-centered Medical Home, 2021 - 2031 |
6.1.4 North America Value-based Healthcare Service Market, Revenues & Volume, By Shared Savings, 2021 - 2031 |
6.1.5 North America Value-based Healthcare Service Market, Revenues & Volume, By Shared Risk, 2021 - 2031 |
6.1.6 North America Value-based Healthcare Service Market, Revenues & Volume, By Bundled Payment, 2021 - 2031 |
6.1.7 North America Value-based Healthcare Service Market, Revenues & Volume, By Capitation Models, 2021 - 2031 |
6.2 North America Value-based Healthcare Service Market, Revenues & Volume, By Payer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Value-based Healthcare Service Market, Revenues & Volume, By Medicare and Medicare Advantage, 2021 - 2031 |
6.2.3 North America Value-based Healthcare Service Market, Revenues & Volume, By Medicaid, 2021 - 2031 |
6.2.4 North America Value-based Healthcare Service Market, Revenues & Volume, By Commercial, 2021 - 2031 |
6.3 North America Value-based Healthcare Service Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Value-based Healthcare Service Market, Revenues & Volume, By Home Health Care, 2021 - 2031 |
6.3.3 North America Value-based Healthcare Service Market, Revenues & Volume, By Institutional Care, 2021 - 2031 |
6.3.4 North America Value-based Healthcare Service Market, Revenues & Volume, By Self-Care, 2021 - 2031 |
6.3.5 North America Value-based Healthcare Service Market, Revenues & Volume, By Hospital Therapy, 2021 - 2031 |
7 North America Value-based Healthcare Service Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Value-based Healthcare Service Market, Revenues & Volume, By Models Type, 2021 - 2031 |
7.2.1 United States (US) Value-based Healthcare Service Market, Revenues & Volume, By Models Type, 2021 - 2031 |
7.2.2 Canada Value-based Healthcare Service Market, Revenues & Volume, By Models Type, 2021 - 2031 |
7.2.3 Rest of North America Value-based Healthcare Service Market, Revenues & Volume, By Models Type, 2021 - 2031 |
7.3 North America Value-based Healthcare Service Market Revenues & Volume Share, By Payer Type, 2021 & 2031F |
7.3.1 United States (US) Value-based Healthcare Service Market, Revenues & Volume, By Payer Type, 2021 - 2031 |
7.3.2 Canada Value-based Healthcare Service Market, Revenues & Volume, By Payer Type, 2021 - 2031 |
7.3.3 Rest of North America Value-based Healthcare Service Market, Revenues & Volume, By Payer Type, 2021 - 2031 |
7.4 North America Value-based Healthcare Service Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Value-based Healthcare Service Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Value-based Healthcare Service Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Value-based Healthcare Service Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Value-based Healthcare Service Market Key Performance Indicators |
9 North America Value-based Healthcare Service Market - Export/Import By Countries Assessment |
10 North America Value-based Healthcare Service Market - Opportunity Assessment |
10.1 North America Value-based Healthcare Service Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Value-based Healthcare Service Market Opportunity Assessment, By Models Type, 2021 & 2031F |
10.3 North America Value-based Healthcare Service Market Opportunity Assessment, By Payer Type, 2021 & 2031F |
10.4 North America Value-based Healthcare Service Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Value-based Healthcare Service Market - Competitive Landscape |
11.1 North America Value-based Healthcare Service Market Revenue Share, By Companies, 2022 |
11.2 North America Value-based Healthcare Service Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here